Skip to main content
Premium Trial:

Request an Annual Quote

William Haseltine, Tim McGrath, Carl Balezentis, James Collins, Mary E. Clutter, Kreatech Biotechnology, Warnex

Premium

Pairings

William Haseltine has become a senior life sciences advisor of CMEA Ventures, the San Francisco-based venture capital firm said on Monday. He is the former chief executive of Human Genome Sciences. Haseltine holds a doctorate in biophysics from Harvard University


Tim McGrath has become senior vice president of molecular services of Genaissance Pharmaceuticals, the company said on Tuesday. He replaces Carl Balezentis, who will resign as senior vice president and president of Lark Technologies, Genaissance's wholly owned subsidiary, effective Aug. 31. Balezentis will receive $262,500 in severance pay over 12 months. MacGrath will receive an annual salary of $200,000.


James Collins will head the directorate for biological sciences at the National Science Foundation starting in October, NSF said last week. He replaces Mary E. Clutter, who is retiring. Collins is currently a professor of natural history and environment at Arizona State University. As assistant director for biological sciences, he will oversee NSF's nearly $580 million annual investment in fundamental biological research. Collins received a BS degree from Manhattan College and a PhD from the University of Michigan.

 

New Releases

Kreatech Biotechnology last week launched its series of PlatinumBright nucleic acid labeling kits that offer its Universal Linkage System labeling molecule bound to a choice of fluorescent dyes, or haptens, and the company's KREApure purification columns, which remove unreacted dye while yielding sample recovery independent of fragment length, Kreatech said.

The company recommended PlatinumBright for fluorescent in situ hybridization applications, filter hybridizations such as northern blots, southern blots, spot blots and dot blot hybridizations, as well as for use with tissue arrays and chIP-on-chip experiments.


Warnex says it will have the first quantitative PCR tests on the food testing market with the first-quarter, 2006, commercialization of a test for detection of Campylobacter jejuni, Campylobacter coli, and Campylobacter lari in poultry rinses. The test's distribution will begin in September, the company said.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.